Newsroom

Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.

Recolony is among the Top 3 biotech startups that are leading the Top100 public voting 2024

The voting process will be opened until July 21 2024. You still have time to cast your vote using your LinkedIn account. You can vote for...

Recolony among the Top100 Swiss Startups

Recolony enters the prestigious Top100 Swiss Startups ranking as newcomer in its first year of existence. The TOP 100 Swiss Startup Award...

We are finalists of >>venture>>, Switzerlands leading startup competition

Recolony was chosen as finalist in the >>venture>> startup competition. On the 19th of May we will pitch in the final and compete against...

Our CEO wins the Falling Walls Breakthrough of Year in the Emerging Talents Category

Ana Montalban-Arques wins the Breakthrough of the Year in the Emerging Talents Category with the presentation “Breaking the Wall of...

Ana Montalban-Arques wins Falling Walls Lab Switzerland

With the presentation entitled “Breaking the Wall of Ineffective Cancer Therapies” Ana won the 1st place in the competition and the...

Ana Montalban-Arques receives support from the BRIDGE programme.

The project "Selected Clostridiales bacteria as novel treatment for solid tumors" has been awarded with the BRIDGE Proof of Concept...

Ana Montalban-Arques receives 150.000CHF from the UZH Entrepreneur Fellowship

With the fellowship Ana Montalban-Arques will develop a formulation of a more storage-stable, lyophilized bacteria and test the efficacy,...